Jie Chai

机构：Shandong Tumor Hospital, Shandong First Medical University · ORCID：0000-0002-0057-4691

发表论文 6 篇 · 总被引 19 次 · h-index 3

代表论文

• Efficacy and Prognostic Factors of Regorafenib in the Treatment of BCLC Stage C Hepatocellular Carcinoma After Failure of the First-Line Therapy (2023 · Drug Design Development and Therapy · 被引 6)
• Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG2023 - 01 Study) (2025 · BMC Cancer · 被引 5)
• Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer (2023 · Pathology & Oncology Research · 被引 4)
• Biliary self-expandable metallic stent combined with iodine-125 seeds in the treatment of malignant biliary obstruction (Bismuth type I or II) (2023 · Surgical Endoscopy · 被引 3)
• Clinical Effectiveness of Transcatheter Arterial Chemoembolization Sequential Microwave Ablation For Lack of Blood Supply in Hepatocellular Carcinoma (2022 · Future Oncology · 被引 1)
• Use of enhanced ct to diagnose lymph node metastasis in patients with resectable advanced gastric carcinoma (2023 · Research Square)